New technologies for human cancer imaging

Journal of Clinical Oncology

Volumn 26, Issue 24, 2008, Pages 4012-4021

  Frangioni, John V ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; GALLIUM 67; INDIUM 111; INDOCYANINE GREEN; IODINE; RADIOISOTOPE; TECHNETIUM 99M;

ACUTE LEUKEMIA; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CHILDHOOD CANCER; CLINICAL TRIAL; COLONOSCOPY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG HALF LIFE; DRUG UPTAKE; ECHOGRAPHY; ESOPHAGUS CANCER; HUMAN; LUNG NON SMALL CELL CANCER; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID TUMOR; X RAY; DIAGNOSTIC IMAGING; METHODOLOGY; NEOPLASM; PATHOLOGY;

DIAGNOSTIC IMAGING; HUMANS; NEOPLASMS;

EID: 50549102118     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.3065     Document Type: Review

References (89)

1. Norton L, Simon R, Brereton HD, et al: Predicting the course of Gompertzian growth. Nature 264:542-545, 1976
2. Groebe K, Mueller-Klieser W: On the relation between size of necrosis and diameter of tumor spheroids. Int J Radiat Oncol Biol Phys 34:395-401, 1996
3. Naumov GN, Akslen LA, Folkman J: Role of angiogenesis in human tumor dormancy: Animal models of the angiogenic switch. Cell Cycle 5:1779-1787, 2006
4. Frangioni JV: Translating in vivo diagnostics into clinical reality. Nat Biotechnol 24:909-913, 2006
5. Choi HS, Liu W, Misra P, et al: Renal clearance of quantum dots. Nat Biotechnol 25:1165-1170, 2007
6. Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, et al: In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Cancer Res 60:5237-5243, 2000
7. Hernández-Sotomayor SM, Arteaga CL, Soler C, et al: Epidermal growth factor stimulates substrate-selective protein-tyrosine-phosphatase activity. Proc Natl Acad Sci U S A 90:7691-7695, 1993
8. Boucher Y, Leunig M, Jain RK: Tumor angiogenesis and interstitial hypertension. Cancer Res 56:4264-4266, 1996
9. Boucher Y, Jain RK: Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: Implications for vascular collapse. Cancer Res 52:5110-5114, 1992
10. Matsumura Y, Oda T, Maeda H: [General mechanism of intratumor accumulation of macromolecules: Advantage of macromolecular therapeutics]. Gan To Kagaku Ryoho14:821-829, 1987
11. Maeda H, Matsumura Y: Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 6:193-210, 1989
12. Hoult DI, Phil D: Sensitivity and power deposition in a high-field imaging experiment. J Magn Reson Imaging 12:46-67, 2000
13. Kelloff GJ, Hoffman JM, Johnson B, et al: Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 11:2785-2808, 2005
14. Kumar R, Chauhan A, Zhuang H, et al: Standardized uptake values of normal breast tissue with 2-deoxy-2-[F-18]fluoro-D: -glucose positron emission tomography: Variations with age, breast density, and menopausal status. Mol Imaging Biol 8:355-362, 2006
15. Boone JM, Lindfors KK: Breast CT: Potential for breast cancer screening and diagnosis. Future Oncol 2:351-356, 2006
16. Boone JM, Kwan AL, Yang K, et al: Computed tomography for imaging the breast. J Mammary Gland Biol Neoplasia 11:103-111, 2006
17. Weinberg IN: Applications for positron emission mammography. Phys Med 21:132-137, 2006 (suppl 1)
18. Hofmann M: From scinti-mammography and metabolic imaging to receptor targeted PET-new principles of breast cancer detection. Phys Med 21:11, 2006 (suppl 1)
19. Dougherty L, Isaac G, Rosen MA, et al: High frame-rate simultaneous bilateral breast DCE-MRI. Magn Reson Med 57:220-225, 2007
20. Ophir J, Cespedes I, Ponnekanti H, et al: Elastography: A quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging 13:111-134, 1991
21. Céspedes I, Ophir J, Ponnekanti H, et al: Elastography: Elasticity imaging using ultrasound with application to muscle and breast in vivo. Ultrason Imaging 15:73-88, 1993
22. Zhi H, Ou B, Luo BM, et al: Comparison of ultrasound elastography, mammography, and sonography in the diagnosis of solid breast lesions. J Ultrasound Med 26:807-815, 2007
23. Plewes DB, Bishop J, Samani A, et al: Visualization and quantification of breast cancer biomechanical properties with magnetic resonance elastography. Phys Med Biol 45:1591-1610, 2000
24. Sinkus R, Lorenzen J, Schrader D, et al: High-resolution tensor MR elastography for breast tumour detection. Phys Med Biol 45:1649-1664, 2000
25. Van Houten EE, Doyley MM, Kennedy FE, et al: Initial in vivo experience with steady-state subzone-based MR elastography of the human breast. J Magn Reson Imaging 17:72-85, 2003
26. Lorenzen J, Sinkus R, Lorenzen M, et al: MR elastography of the breast: Preliminary clinical results. Rofo 174:830-834, 2002
27. Nioka S, Miwa M, Orel S, et al: Optical imaging of human breast cancer. Adv Exp Med Biol 361:171-179, 1994
28. Hsiang D, Shah N, Yu H, et al: Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer. Technol Cancer Res Treat 4:549-558, 2005
29. Carpenter CM, Pogue BW, Jiang S, et al: Image-guided optical spectroscopy provides molecular-specific information in vivo: MRI-guided spectroscopy of breast cancer hemoglobin, water, and scatterer size. Opt Lett 32:933-935, 2007
30. Bhushan KR, Tanaka E, Frangioni JV: Synthesis of conjugatable bisphosphonates for molecular imaging of large animals. Angew Chem Int Ed Engl 46:7969-7971, 2007
31. Georgakoudi I, Van Dam J: Characterization of dysplastic tissue morphology and biochemistry in Barrett's esophagus using diffuse reflectance and light scattering spectroscopy. Gastrointest Endosc Clin N Am 13:297-308, 2003
32. Kim YL, Turzhitsky VM, Liu Y, et al: Low-coherence enhanced backscattering: Review of principles and applications for colon cancer screening. J Biomed Opt 11:041125, 2006
33. Lovat LB, Johnson K, Mackenzie GD, et al: Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's oesophagus. Gut 55:1078-1083, 2006
34. Perelman LT: Optical diagnostic technology based on light scattering spectroscopy for early cancer detection. Expert Rev Med Devices 3:787-803, 2006
35. Orfanoudaki IM, Themelis GC, Sifakis SK, et al: A clinical study of optical biopsy of the uterine cervix using a multispectral imaging system. Gynecol Oncol 96:119-131, 2005
36. Huh WK, Cestero RM, Garcia FA, et al: Optical detection of high-grade cervical intraepithelial neoplasia in vivo: Results of a 604-patient study. Am J Obstet Gynecol 190:1249-1257, 2004
37. Arrazola P, Mullani NA, Abramovits W: Derm-Lite II: An innovative portable instrument for dermoscopy without the need of immersion fluids. Skinmed 4:78-83, 2005
38. Brand S, Poneros JM, Bouma BE, et al: Optical coherence tomography in the gastrointestinal tract. Endoscopy 32:796-803, 2000
39. DaCosta RS, Wilson BC, Marcon NE: Optical techniques for the endoscopic detection of dysplastic colonic lesions. Curr Opin Gastroenterol 21:70-79, 2005
40. Kennedy JC, Marcus SL, Pottier RH: Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): Mechanisms and clinical results. J Clin Laser Med Surg 14:289-304, 1996
41. Wallace MB, Sullivan D, Rustgi AK: Advanced imaging and technology in gastrointestinal neoplasia: Summary of the AGA-NCI Symposium October 4-5, 2004. Gastroenterology 130:1333-1342, 2006
42. Alencar H, Funovics MA, Figueiredo J, et al: Colonic adenocarcinomas: Near-infrared microcatheter imaging of smart probes for early detection - Study in mice. Radiology 244:232-238, 2007
43. Pickhardt PJ, Kim DH: CT colonography (virtual colonoscopy): A practical approach for population screening. Radiol Clin North Am 45:361-375, 2007
44. Ajaj W, Goyen M: MR imaging of the colon: "technique, indications, results and limitations". Eur J Radiol 61:415-423, 2007
45. Abdel Razek AA, Abu Zeid MM, Bilal M, et al: Virtual CT colonoscopy versus conventional colonoscopy: A prospective study. Hepatogastroenterology 52:1698-1702, 2005
46. Park SH, Lee SS, Choi EK, et al: Flat colorectal neoplasms: Definition, importance, and visualization on CT colonography. AJR Am J Roentgenol 188:953-959, 2007
47. Gabriel M, Decristoforo C, Kendler D, et al: 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: Comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 48:508-518, 2007
48. Cherry SR: The 2006 Henry N. Wagner Lecture: Of mice and men (and positrons) - Advances in PET imaging technology. J Nucl Med 47:1735-1745, 2006
49. Surti S, Kuhn A, Werner ME, et al: Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med 48:471-480, 2007
50. Golman K, Zandt RI, Lerche M, et al: Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res 66:10855-10860, 2006
51. Jonischkeit T, Bommerich U, Stadler J, et al: Generating long-lasting 1H and 13C hyperpolarization in small molecules with parahydrogen-induced polarization. J Chem Phys 124:201109, 2006
52. Zhang S, Merritt M, Woessner DE, et al: PARACEST agents: Modulating MRI contrast via water proton exchange. Acc Chem Res 36:783-790, 2003
53. Vinogradov E, He H, Lubag A, et al: MRI detection of paramagnetic chemical exchange effects in mice kidneys in vivo. Magn Reson Med 58:650-655, 2007
54. Humblet V, Misra P, Frangioni JV: An HPLC/mass spectrometry platform for the development of multimodality contrast agents and targeted therapeutics: Prostate-specific membrane antigen small molecule derivatives. Contrast Media Mol Imaging 1:196-211, 2006
55. Kelloff GJ, Krohn KA, Larson SM, et al: The progress and promise of molecular imaging probes in oncologic drug development. Clin Cancer Res 11:7967-7985, 2005
56. Mammen M, Choi SK, Whitesides GM: Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed Engl 37:2754-2794, 1998
57. Handl HL, Vagner J, Han H, et al: Hitting multiple targets with multimeric ligands. Expert Opin Ther Targets 8:565-586, 2004
58. Misra P, Humblet V, Pannier N, et al: Production of multimeric prostate-specific membrane antigen small-molecule radiotracers using a solid-phase 99mTc preloading strategy. J Nucl Med 48:1379-1389, 2007
59. Graff CP, Chester K, Begent R, et al: Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 degrees C. Protein Eng Des Sel 17:293-304, 2004
60. Kenmoku S, Urano Y, Kojima H, et al: Development of a highly specific rhodamine-based fluorescence probe for hypochlorous acid and its application to real-time imaging of phagocytosis. J Am Chem Soc 129:7313-7318, 2007
61. Nahmias C, Hanna WT, Wahl LM, et al: Time course of early response to chemotherapy in nonsmall cell lung cancer patients with 18F-FDG PET/CT. J Nucl Med 48:744-751, 2007
62. Lordick F, Ott K, Krause BJ, et al: PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: The MUNICON phase II trial. Lancet Oncol 8:797-805, 2007
63. Kelloff GJ, Sullivan DM, Wilson W, et al: FDG-PET Lymphoma Demonstration Project Invitational Workshop. Acad Radiol 14:330-339, 2007
64. Rottey S, Slegers G, Van Belle S, et al: Sequential 99mTc- hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. J Nucl Med 47:1813-1818, 2006
65. Kartachova M, Haas RL, Olmos RA, et al: In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: Visual analysis in relation to treatment response. Radiother Oncol 72:333-339, 2004
66. Kartachova M, van Zandwijk N, Burgers S, et al: Prognostic significance of 99mTc Hynic-rhannexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J Clin Oncol 25:2534-2539, 2007
67. Chou CP, Wu MT, Chang HT, et al: Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: A pilot study. Acad Radiol 14:561-573, 2007
68. Cerussi A, Hsiang D, Shah N, et al: Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci U S A 104:4014-4019, 2007
69. Nishio T, Ogino T, Nomura K, et al: Dosevolume delivery guided proton therapy using beam on-line PET system. Med Phys 33:4190-4197, 2006
70. Frangioni JV: In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7:626-634, 2003
71. De Grand AM, Frangioni JV: An operational near-infrared fluorescence imaging system prototype for large animal surgery. Technol Cancer Res Treat 2:553-562, 2003
72. Tanaka E, Choi HS, Fujii H, et al: Image-guided oncologic surgery using invisible light: Completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol 13:1671-1681, 2006
73. Reynolds JS, Troy TL, Mayer RH, et al: Imaging of spontaneous canine mammary tumors using fluorescent contrast agents. Photochem Photobiol 70:87-94, 1999
74. Ohnishi S, Lomnes SJ, Laurence RG, et al: Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping. Mol Imaging 4:172-181, 2005
75. Knapp DW, Adams LG, Degrand AM, et al: Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Eur Urol 52:1700-1708, 2007
76. Parungo CP, Colson YL, Kim SW, et al: Sentinel lymph node mapping of the pleural space. Chest 127:1799-1804, 2005
77. Parungo CP, Ohnishi S, Kim SW, et al: Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. J Thorac Cardiovasc Surg 129:844-850, 2005
78. Parungo CP, Soybel DI, Colson YL, et al: Lymphatic drainage of the peritoneal space: A pattern dependent on bowel lymphatics. Ann Surg Oncol 14:286-298, 2007
79. Figueiredo JL, Alencar H, Weissleder R, et al: Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer. Int J Cancer 118:2672-2677, 2006
80. Humblet V, Lapidus R, Williams LR, et al: High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigen. Mol Imaging 4:448-462, 2005
81. Ke S, Wen X, Gurfinkel M, et al: Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 63:7870-7875, 2003
82. Li C, Wang W, Wu Q, et al: Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl Med Biol 33:349-358, 2006
83. Tanaka E, Ohnishi S, Laurence RG, et al: Real-time intraoperative ureteral guidance using invisible near-infrared fluorescence. J Urol 178:2197-2202, 2007
84. Penson R, Horowitz N, Kassis E, et al: Laparoscopy in the near infrared with ICG detects microscopic tumor in women with ovarian cancer. Presented at Annual Meeting of the Society for Molecular Imaging, Big Island, HI, August 30 to September 2, 2006
85. Jin L, Hope KJ, Zhai Q, et al: Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 12:1167-1174, 2006
86. Ries LAG, Melbert D, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2004, Section XX-VIII, Childhood Cancer by Site, Incidence, Survival and Mortality. Bethesda, MD, National Cancer Institute, 2007. http://seer.cancer. gov/csr/1975_2004/
87. Pashankar FD, O'Dorisio MS, Menda Y: MIBG and somatostatin receptor analogs in children: Current concepts on diagnostic and therapeutic use. J Nucl Med 46:55S-61S, 2005 (suppl 1)
88. Frangioni JV, Hajjar RJ: In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 110:3378-3383, 2004
89. Sweet IR, Cook DL, Lernmark A, et al: Noninvasive imaging of beta cell mass: A quantitative analysis. Diabetes Technol Ther 6:652-659, 2004